Health
Weight Loss Drug Tied to Lower Eye Disease Risk in Diabetics
Large-scale study finds GLP-1 receptor agonists significantly reduce diabetic retinopathy risk and other eye complications in type 2 diabetes patients.
Key Takeaways
- A large-scale study finds GLP-1 receptor agonist users have significantly lower risk of diabetic retinopathy and eye complications
- The findings add eye health to a growing list of benefits including cardiovascular and renal protection from these drugs
- Diabetic retinopathy is the leading cause of blindness among working-age adults, affecting one-third of diabetes patients
DE
DT Editorial AI··via medicalxpress.com